Inhibits excessive production of reactive oxygen species |
(1) Increase cell survival and reduce intracellular ROS level |
[24] |
|
Improve the activity of antioxidant enzymes |
(1) Improve the activities of SOD and GSH-Px |
[32] |
(2) Improve the level of GSH and the activities of SOD and GSH-Px |
[32] |
(3) Increase antioxidant enzyme activity |
[18, 39] |
|
Inhibition of NO production |
(1) Negative effects on LPS + IFN-γ stimulation, NO and ROS formation, and iNOS activity |
[16] |
(2) Inhibition of NO formation and improvement of neurodegenerative conditions |
[18] |
(3) To prevent neuronal apoptosis by regulating the increase of NO and iNOS |
[44] |
|
Inhibits mitochondrial dysfunction |
(1) Prevention of apoptosis induced by fiber Aβ1-42 through mitochondrial-dependent and death receptor pathways |
[36] |
(2) Protecting brain mitochondrial function by decreasing MMP opening |
[46] |
(3) Inhibition of mitochondrial dysfunction |
[34, 47] |
Inhibition of apoptosis |
Attenuated mitochondria-dependent caspase cascade; inhibits the leakage of cytochrome C from mitochondria to the cytoplasm, and weakens the activation of caspase-3 and cleavage of polyADP ribose polymerase |
[27, 39] |
|
Regulation of NF-κB pathway |
(1) Inhibition of NF-κB activation and LPS-induced acute inflammatory response |
[43] |
(2) Inhibition of NF-κB activation and protection of mitochondrial function |
[46] |
(3) Reducing microglia-mediated neuroinflammatory response by inhibiting NF-κB signaling pathway |
[15, 16] |
|
Regulation of neurotrophic factors |
(1) Hippocampus BDNF was significantly increased, which was positively correlated with synaptophysin expression; “Normalize” presynaptic proteins and their associated signaling pathways |
[35] |
(2) Enhance the expression of BDNF |
[58, 60] |
|
Increase the density of muscarinic receptors in the brain |
(1) Protective effect on cholinergic |
[49] |
(2) Improve learning ability and increase the density of muscarinic receptors in the brain |
[62] |
(3) Regulating cholinergic nervous system function through the influence on ChAT |
[64] |
|
The expression levels of Bcl-2 and Bax were regulated |
(1) Stimulate Bcl-2 expression and inhibit Bax expression |
[67] |
(2) Inhibition of the increase of Bax expression and decrease of Bcl-2 expression induced by Aβ25-35 |
[68] |